Instruction for use: Normosang

Dosage form: Concentrate for solution for infusions

Active substance: Heminum

ATX

B06AB Blood preparations other

Pharmacological group

Stimulators of hematopoiesis

The nosological classification (ICD-10)

E80 Disorders of porphyrin and bilirubin metabolism: Urochoproporphyria; Late skin porphyria; Functional hyperbilirubinemia; Disturbances of pigmental metabolism; Porphyrin disease; Erythropoietic protoporphyria; Erythropoietic uroporporphia; Symptomatic porphyria

Composition and release form

1 ml of the concentrate for the preparation of infusions contains hemin 25 mg and arginine 26.7 mg, in ampoules of 10 ml; In the package 4 pcs.

Pharmachologic effect

Mode of action - Erythropoietic.

Decreased porphyrin formation.

Indication of the drug Normosang

Acute porphyria.

Contraindications

Hypersensitivity.

Side effects

Soreness at the injection site.

Interaction

Incompatible with barbiturates.

Dosing and Administration

IV by drop infusion, 3 mg / kg once a day, the duration of infusion - 15 minutes. The course of treatment is 4-7 days.

Storage conditions of the drug Normosang

Keep out of the reach of children.

Shelf life of the drug Normosang

2 years.

Do not use after the expiry date printed on the package.